NUDT15 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method

NUDT15 gene prod met act imp Bld/T-Imp

Definition

The NUDT15 gene product metabolic activity interpretation is determined by the reporting lab and returned with the structured test results. It indicates the lab's interpretation of the phenotype, regardless of whether the lab assay's method was genetic or enzymatic. This specific interpretation would be considered a separate observation made by the lab in addition to the primary reported results (e.g., genotype or measured activity level) and it could be included with other assay-specific observations, which would ideally support the interpretation value. The lab may use the Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for reporting DPYD gene product metabolic activity (phenotype).

Activ; Actvty; Blood; Drug metabolism; Gene prod met act imp; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; NUDT15 gene prod met act imp; Ordinal; PCR; Phenotype; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue